bullish
EQT/Dechra Pharmaceuticals: Recommended Offer
Jesus has highlighted this Insight as a Top Pick
557 Views02 Jun 2023 19:54
In spite of negative trading updated, EQT has followed in its pursuit of Dechra and today both have agreed a fair, in my view, 3,875p/share offer (21.4x EV/Fwd EBITDA, 30.2x Fwd P/E).
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top Quartile
Jesus Rodriguez Aguilar
European Event-Driven Analyst
Price Chart(Sign Up to Access)
x